ZA200303337B - The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator. - Google Patents
The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator. Download PDFInfo
- Publication number
- ZA200303337B ZA200303337B ZA200303337A ZA200303337A ZA200303337B ZA 200303337 B ZA200303337 B ZA 200303337B ZA 200303337 A ZA200303337 A ZA 200303337A ZA 200303337 A ZA200303337 A ZA 200303337A ZA 200303337 B ZA200303337 B ZA 200303337B
- Authority
- ZA
- South Africa
- Prior art keywords
- sub
- weight
- composition
- parts
- dilution
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 239000012670 alkaline solution Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- 230000000694 effects Effects 0.000 claims abstract description 31
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 20
- 239000004115 Sodium Silicate Substances 0.000 claims abstract description 17
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910052911 sodium silicate Inorganic materials 0.000 claims abstract description 17
- 235000019795 sodium metasilicate Nutrition 0.000 claims abstract description 15
- 229910021538 borax Inorganic materials 0.000 claims abstract description 14
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 14
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 12
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims abstract description 12
- 235000019345 sodium thiosulphate Nutrition 0.000 claims abstract description 12
- 229910000027 potassium carbonate Inorganic materials 0.000 claims abstract description 10
- 235000019786 weight gain Nutrition 0.000 claims abstract description 8
- 230000004584 weight gain Effects 0.000 claims abstract description 8
- 230000003308 immunostimulating effect Effects 0.000 claims abstract description 5
- 230000003213 activating effect Effects 0.000 claims abstract description 4
- 238000010790 dilution Methods 0.000 claims description 30
- 239000012895 dilution Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 22
- 241001465754 Metazoa Species 0.000 claims description 20
- 244000144972 livestock Species 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- ZSILVJLXKHGNPL-UHFFFAOYSA-L S(=S)(=O)([O-])[O-].[Ag+2] Chemical compound S(=S)(=O)([O-])[O-].[Ag+2] ZSILVJLXKHGNPL-UHFFFAOYSA-L 0.000 claims description 8
- 230000012010 growth Effects 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 239000003337 fertilizer Substances 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000011684 sodium molybdate Substances 0.000 claims description 5
- 235000015393 sodium molybdate Nutrition 0.000 claims description 5
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 230000004069 differentiation Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 244000052769 pathogen Species 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- -1 feedstuff Substances 0.000 claims description 2
- 230000035784 germination Effects 0.000 claims description 2
- 230000007124 immune defense Effects 0.000 claims description 2
- 210000000987 immune system Anatomy 0.000 claims description 2
- 210000004881 tumor cell Anatomy 0.000 claims description 2
- 241000282412 Homo Species 0.000 claims 3
- 230000001737 promoting effect Effects 0.000 claims 2
- 239000011734 sodium Substances 0.000 abstract description 11
- 210000002865 immune cell Anatomy 0.000 abstract description 7
- 230000006872 improvement Effects 0.000 abstract description 7
- 238000002255 vaccination Methods 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000016784 immunoglobulin production Effects 0.000 abstract description 4
- 208000035240 Disease Resistance Diseases 0.000 abstract description 3
- 230000003211 malignant effect Effects 0.000 abstract description 3
- 238000003306 harvesting Methods 0.000 abstract description 2
- 230000003612 virological effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 53
- 238000012360 testing method Methods 0.000 description 18
- 210000001744 T-lymphocyte Anatomy 0.000 description 14
- 241000209094 Oryza Species 0.000 description 13
- 210000000265 leukocyte Anatomy 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 210000004698 lymphocyte Anatomy 0.000 description 10
- 241000283690 Bos taurus Species 0.000 description 8
- 108010033737 Pokeweed Mitogens Proteins 0.000 description 8
- 210000002503 granulosa cell Anatomy 0.000 description 8
- 210000005259 peripheral blood Anatomy 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 108010047620 Phytohemagglutinins Proteins 0.000 description 7
- 241000220324 Pyrus Species 0.000 description 7
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 7
- 239000011886 peripheral blood Substances 0.000 description 7
- 230000001885 phytohemagglutinin Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 108010004729 Phycoerythrin Proteins 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 108010062580 Concanavalin A Proteins 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 235000014443 Pyrus communis Nutrition 0.000 description 5
- 241000282887 Suidae Species 0.000 description 5
- 208000037386 Typhoid Diseases 0.000 description 5
- 210000003719 b-lymphocyte Anatomy 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 210000001165 lymph node Anatomy 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 235000021017 pears Nutrition 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000001082 somatic cell Anatomy 0.000 description 5
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 5
- 201000008297 typhoid fever Diseases 0.000 description 5
- 102000043131 MHC class II family Human genes 0.000 description 4
- 108091054438 MHC class II family Proteins 0.000 description 4
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 3
- 206010008631 Cholera Diseases 0.000 description 3
- 241000276457 Gadidae Species 0.000 description 3
- 240000001987 Pyrus communis Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 210000002459 blastocyst Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 2
- 102000043129 MHC class I family Human genes 0.000 description 2
- 108091054437 MHC class I family Proteins 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 229960005004 cholera vaccine Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 102000046949 human MSC Human genes 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000002420 orchard Substances 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 150000004686 pentahydrates Chemical class 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009696 proliferative response Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241001464974 Cutibacterium avidum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102220467492 HEPACAM family member 2_H42A_mutation Human genes 0.000 description 1
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000930801 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 2 chain Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 210000004460 N cell Anatomy 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000918585 Pythium aphanidermatum Species 0.000 description 1
- 241001454523 Quillaja saponaria Species 0.000 description 1
- 235000009001 Quillaja saponaria Nutrition 0.000 description 1
- 101150107341 RERE gene Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 235000021052 average daily weight gain Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 230000005089 fruit drop Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 210000000207 lymphocyte subset Anatomy 0.000 description 1
- 230000001589 lymphoproliferative effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229940055009 propionibacterium avidum Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000070054A KR100331952B1 (ko) | 2000-11-23 | 2000-11-23 | 다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200303337B true ZA200303337B (en) | 2003-11-19 |
Family
ID=36747572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200303337A ZA200303337B (en) | 2000-11-23 | 2003-04-30 | The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator. |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US6447810B1 (de) |
| EP (1) | EP1339415B1 (de) |
| JP (2) | JP4183069B2 (de) |
| KR (1) | KR100331952B1 (de) |
| CN (1) | CN1254199C (de) |
| AT (1) | ATE357240T1 (de) |
| AU (2) | AU2712001A (de) |
| BR (1) | BR0115578A (de) |
| CA (1) | CA2427856C (de) |
| DE (1) | DE60127443T2 (de) |
| ES (1) | ES2278719T3 (de) |
| MX (1) | MXPA03004455A (de) |
| RU (1) | RU2257903C2 (de) |
| WO (1) | WO2002041903A1 (de) |
| ZA (1) | ZA200303337B (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6977245B2 (en) | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| WO2001051500A1 (en) | 2000-01-14 | 2001-07-19 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| JP2005500043A (ja) * | 2001-07-03 | 2005-01-06 | ローディア インコーポレイティド | 動物屠体又は植物素材の処理方法 |
| US7666674B2 (en) | 2001-07-27 | 2010-02-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo |
| AU2002361468A1 (en) * | 2001-08-14 | 2003-03-18 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human S | Method for rapid generation of mature dendritic cells |
| US20090227452A1 (en) * | 2001-09-14 | 2009-09-10 | Birthisel Timothy D | Spent fermented grain soil additive |
| US7615227B2 (en) * | 2001-12-20 | 2009-11-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce angiogenesis |
| US8466116B2 (en) | 2001-12-20 | 2013-06-18 | The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
| US8263091B2 (en) * | 2002-09-18 | 2012-09-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides |
| US7354613B2 (en) * | 2002-12-23 | 2008-04-08 | Danisco A/S | Method for treating processed food products |
| KR100739347B1 (ko) * | 2005-05-09 | 2007-07-16 | 장정만 | 규산소다를 이용한 식물성장제의 조성물 및 제조제법 |
| CN1316892C (zh) * | 2005-07-19 | 2007-05-23 | 佛山科学技术学院 | 一种草坪草防病增抗剂 |
| ES2652114T3 (es) * | 2007-10-15 | 2018-01-31 | 7 Oaks Pharmaceutical Corporation | Una disolución que contiene silicato para uso en el tratamiento de melanoma |
| CN101326963B (zh) * | 2008-03-03 | 2011-06-22 | 北京神州圣业科技有限公司 | 一种碱性阳离子饲料免疫增强剂溶液、生产方法及其用途 |
| US20100016162A1 (en) * | 2008-07-11 | 2010-01-21 | Brian Goodwin | Foliarly applicable silicon nutrition compositions & methods |
| CA2767168C (en) * | 2009-07-08 | 2019-04-09 | Hope Medical Enterprises, Inc. D.B.A. Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
| CN102740689B (zh) | 2009-09-03 | 2015-09-23 | Fb科技控股公司 | 种子处理组合物及方法 |
| US20110059189A1 (en) * | 2009-09-08 | 2011-03-10 | Cisne Enterprises Inc. | Method and composition for treating cancer, effecting apoptosis and treating retroviral infections |
| CA2775407A1 (en) * | 2009-09-28 | 2011-03-31 | Fbsciences Holdings, Inc. | Fertilizer compositions and methods |
| EP2371220B2 (de) * | 2010-03-31 | 2018-01-17 | Taminco | Stabilisierte, bioverfügbare, lösliche Silikatlösung |
| CN102239959B (zh) * | 2010-05-11 | 2013-05-15 | 姜明一 | 一种离子激活液的制备方法 |
| US9485991B2 (en) | 2012-01-12 | 2016-11-08 | Fbsciences Holdings, Inc. | Modulation of plant biology |
| CN102613242A (zh) * | 2012-03-05 | 2012-08-01 | 佛山科学技术学院 | 一种草坪草抗逆增绿剂及其使用方法 |
| JP5991543B2 (ja) * | 2013-09-04 | 2016-09-14 | 市川 好男 | 制癌剤 |
| GB201402672D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
| KR101742152B1 (ko) * | 2014-02-27 | 2017-06-01 | 바로돈에스에프주식회사 | 비특이성 면역증강제 조성물 및 그 제조방법, 그리고 그 용도 |
| US10384985B2 (en) | 2014-06-06 | 2019-08-20 | B.K. Consultants, Inc. | Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants |
| WO2015187974A1 (en) * | 2014-06-06 | 2015-12-10 | Ovokaitys Todd Frank | Methods and compositions for increasing the bioactivity of nutrients |
| CN104206748A (zh) * | 2014-09-26 | 2014-12-17 | 江苏农林职业技术学院 | 一种提高种母猪免疫力的饲料添加剂及其制备方法和应用 |
| CN104313104B (zh) * | 2014-09-26 | 2017-05-24 | 江苏农林职业技术学院 | 一种离子蛋白肽及其制备方法和应用 |
| JP6371750B2 (ja) * | 2015-10-07 | 2018-08-08 | 株式会社クラフトマン | 免疫活性剤の製造方法と製造装置 |
| WO2020036555A2 (en) * | 2018-05-02 | 2020-02-20 | Zumrutdal Emin | An alkaline dialysate |
| KR102305003B1 (ko) * | 2021-04-20 | 2021-09-23 | 김준석 | 액상규산나트륨의 제조방법 및 이로부터 제조된 액상규산나트륨 |
| CN113317395A (zh) * | 2021-06-25 | 2021-08-31 | 河南牧翔动物药业有限公司 | 一种高效改善酸化剂功能的组合物及其制备方法 |
| KR20240015909A (ko) | 2022-07-28 | 2024-02-06 | 경성대학교 산학협력단 | 메타규소를 유효성분으로 포함하는 혈관 평활근 세포 증식억제용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS526741A (en) * | 1975-06-30 | 1977-01-19 | Philadelphia Quartz Co | Starchhsilicic acid adhesive and production method |
| JPH06279202A (ja) * | 1993-03-25 | 1994-10-04 | Taihei Kagaku Sangyo Kk | 切り花鮮度保持剤 |
| JP3624916B2 (ja) * | 1995-03-29 | 2005-03-02 | 三菱瓦斯化学株式会社 | オーシスト殺滅剤 |
| KR100254037B1 (ko) * | 1997-12-29 | 2000-04-15 | 김태한 | 칼륨을 주제로 한 알칼리성 수질 및 토양 개량제 수용액 조성물과 그 조성물의 제조방법 |
| CN1232859A (zh) * | 1998-04-23 | 1999-10-27 | 崔松哲 | 以钾剂为主的水溶液组合物及其制造方法和用途 |
| KR20000014161A (ko) * | 1998-08-18 | 2000-03-06 | 김태한 | 고기능성 발효사료조성물 및 그 제조방법 |
| KR100288600B1 (ko) * | 1999-03-03 | 2001-04-16 | 김승일 | 기능성 알칼리토 이온화 화합물로 구성된 식품첨가제 조성물 및그의 제조방법 |
| KR100330993B1 (ko) * | 2000-02-18 | 2002-04-01 | 김승일 | 액상 사료 첨가제 및 이의 제조방법 |
| KR102143198B1 (ko) * | 2018-11-22 | 2020-08-11 | (주)바이오벤 | 과열수증기를 이용한 발아통곡물 제조방법, 이를 포함하는 체중조절용 식품조성물 및 이의 제조방법 |
-
2000
- 2000-11-23 KR KR1020000070054A patent/KR100331952B1/ko active IP Right Grant
-
2001
- 2001-01-03 AU AU2712001A patent/AU2712001A/xx active Pending
- 2001-01-03 DE DE60127443T patent/DE60127443T2/de not_active Expired - Lifetime
- 2001-01-03 JP JP2002544081A patent/JP4183069B2/ja not_active Expired - Fee Related
- 2001-01-03 BR BR0115578-4A patent/BR0115578A/pt not_active IP Right Cessation
- 2001-01-03 ES ES01901569T patent/ES2278719T3/es not_active Expired - Lifetime
- 2001-01-03 CA CA002427856A patent/CA2427856C/en not_active Expired - Lifetime
- 2001-01-03 RU RU2003117460/15A patent/RU2257903C2/ru not_active IP Right Cessation
- 2001-01-03 AU AU2001227120A patent/AU2001227120B2/en not_active Ceased
- 2001-01-03 EP EP01901569A patent/EP1339415B1/de not_active Expired - Lifetime
- 2001-01-03 WO PCT/KR2001/000009 patent/WO2002041903A1/en active IP Right Grant
- 2001-01-03 MX MXPA03004455A patent/MXPA03004455A/es active IP Right Grant
- 2001-01-03 AT AT01901569T patent/ATE357240T1/de not_active IP Right Cessation
- 2001-01-08 US US09/755,020 patent/US6447810B1/en not_active Expired - Lifetime
- 2001-08-29 CN CNB011258497A patent/CN1254199C/zh not_active Expired - Fee Related
-
2002
- 2002-01-14 US US10/043,162 patent/US6673375B2/en not_active Expired - Fee Related
-
2003
- 2003-04-25 US US10/422,696 patent/US6884440B2/en not_active Expired - Fee Related
- 2003-04-25 US US10/423,264 patent/US6899900B2/en not_active Expired - Fee Related
- 2003-04-30 ZA ZA200303337A patent/ZA200303337B/en unknown
-
2007
- 2007-08-20 JP JP2007213231A patent/JP4756015B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1339415A4 (de) | 2005-10-19 |
| US6899900B2 (en) | 2005-05-31 |
| RU2257903C2 (ru) | 2005-08-10 |
| JP2004513967A (ja) | 2004-05-13 |
| BR0115578A (pt) | 2003-07-29 |
| CA2427856C (en) | 2007-12-04 |
| MXPA03004455A (es) | 2005-04-19 |
| AU2001227120B2 (en) | 2004-10-28 |
| JP2008001714A (ja) | 2008-01-10 |
| US20020098205A1 (en) | 2002-07-25 |
| CN1254199C (zh) | 2006-05-03 |
| DE60127443D1 (de) | 2007-05-03 |
| US20020098980A1 (en) | 2002-07-25 |
| ES2278719T3 (es) | 2007-08-16 |
| KR20010044142A (ko) | 2001-06-05 |
| CN1356061A (zh) | 2002-07-03 |
| JP4756015B2 (ja) | 2011-08-24 |
| US6884440B2 (en) | 2005-04-26 |
| US20030185900A1 (en) | 2003-10-02 |
| EP1339415A1 (de) | 2003-09-03 |
| AU2712001A (en) | 2002-06-03 |
| WO2002041903A1 (en) | 2002-05-30 |
| US6673375B2 (en) | 2004-01-06 |
| EP1339415B1 (de) | 2007-03-21 |
| US20030206967A1 (en) | 2003-11-06 |
| US6447810B1 (en) | 2002-09-10 |
| DE60127443T2 (de) | 2007-07-12 |
| JP4183069B2 (ja) | 2008-11-19 |
| CA2427856A1 (en) | 2002-05-30 |
| ATE357240T1 (de) | 2007-04-15 |
| KR100331952B1 (ko) | 2002-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001227120B2 (en) | The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator | |
| AU2001227120A1 (en) | The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator | |
| Latham | Human nutrition in the developing world | |
| Powell et al. | Algae feeding in humans | |
| Anderson et al. | A study of the nutritional status and food habits of Otomi Indians in the Mezquital Valley of Mexico | |
| Fraenkel et al. | Bt, a new vitamin of the B-group and its relation to the folic acid group, and other anti-anaemia factors | |
| CN101239091B (zh) | 防治幽门螺杆菌感染的组合物 | |
| Wang et al. | Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2 | |
| Maxwell | Osteomalacia and diet. | |
| JPH08205819A (ja) | 保健用飲食品 | |
| KR20020096488A (ko) | 다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과비특이 면역증강제로서의 용도 | |
| Fox | Diet in relation to health in South Africa: biochemical aspect | |
| Kon | Section D. The Nutritional value of milk and milk products | |
| Sulistyowati et al. | Milk Production and Milk Income Over Feed Cost of Dairy Cow Fed Fermented Cassava, Tabut Block, and Concentrate Containing Curcuma xanthorhiza and Yeast | |
| Sugiuka et al. | The influence of certain limited diets upon tumor susceptibility and growth in albino rats and mice | |
| Jones | The New Zealand Letter | |
| Mccollum | A decade of progress in nutrition | |
| Kon | Section E. The Nutritional Value of Milk and Milk Products | |
| ANDREWS | iection of CZoinparative el) e'tcine. | |
| Bassir | Biochemical aspects of human malnutrition in the tropics | |
| Lyon | Science and post-war relief | |
| Cowell et al. | Discussion On Food Deficiency Conditions In Relation To Preventable Illness | |
| IS | Due to technical reasons the numeration of the volumes started with Volume Vas a continuation of the earlier journal Physiologia comparata et Oecologia, of which four volumes have been published. | |
| Evans | Science serves your farm and home. |